Effects of olopatadine ophthalmic: A Synthesis of Findings from 13 Studies

  1. Home
  2. Effects of olopatadine ophthalmic
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of olopatadine ophthalmic: A Synthesis of Findings from 13 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of olopatadine ophthalmic: A Synthesis of Findings from 13 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Olopatadine ophthalmic solution has been shown to be effective in treating the symptoms of allergic conjunctivitis, including itchy eyes, redness, swelling, and tearing. 4 , 2 This medication works by blocking histamine receptors and stabilizing mast cells, which helps to reduce the release of inflammatory chemicals that cause these symptoms. 4 , 8 It is also effective in preventing allergic conjunctivitis, especially when used in a timely manner before allergen exposure. 6

Olopatadine is generally well-tolerated, with few side effects reported. 6 However, there have been some reports of fixed drug eruption, a rare skin reaction that occurs after topical application. 9

Benefits and Risks

Benefits Summary

Olopatadine ophthalmic solution is a safe and effective treatment for allergic conjunctivitis. 4 , 2 It can provide rapid relief from symptoms such as itchy eyes, redness, and swelling. 2 It is also effective in preventing allergic conjunctivitis if used before allergen exposure. 6

Risks Summary

The most common side effect of olopatadine ophthalmic solution is a temporary burning or stinging sensation. 4 A rare but serious side effect is fixed drug eruption, which is a skin reaction that can occur after topical application. 9

Comparison between Studies

Similarities between Studies

Several studies have shown that olopatadine ophthalmic solution is effective in treating the symptoms of allergic conjunctivitis. 4 , 2 , 6 All studies have confirmed that olopatadine acts as a histamine H1 receptor antagonist and mast cell stabilizer. 4 , 8

Differences between Studies

Some studies have shown that olopatadine can be effective in treating nasal symptoms in patients with allergic conjunctivitis or rhinoconjunctivitis. 1 Another study suggests that olopatadine is safe for use in patients with both allergic conjunctivitis and dry eye. 2 While most studies have reported olopatadine to be safe, there have been reports of a rare side effect called fixed drug eruption. 9

Consistency and Contradictions in Results

The majority of studies suggest that olopatadine ophthalmic solution is effective in treating allergic conjunctivitis. 4 , 2 , 6 However, there are some inconsistencies in the reported efficacy and safety of olopatadine between different studies. 1 Further research is needed to clarify these discrepancies.

Real-Life Application Considerations

Olopatadine ophthalmic solution can be a useful treatment option for patients with allergic conjunctivitis. 4 , 2 It is important to note that while olopatadine is generally safe, there is a rare risk of developing fixed drug eruption. 9 If you experience any unusual side effects while using olopatadine, it is important to consult with a doctor.

Limitations of Current Research

Some studies on olopatadine have relatively small sample sizes and may not be representative of the general population. 1 Additionally, there is a lack of comprehensive comparisons between olopatadine and other allergy treatments. 6

Future Research Directions

Larger-scale clinical trials are needed to further investigate the efficacy and safety of olopatadine ophthalmic solution. 1 More research is also required to compare olopatadine with other allergy treatments and identify the most effective treatment options for different patients. 6

Conclusion

Olopatadine ophthalmic solution is a promising treatment option for allergic conjunctivitis, offering potential benefits for managing symptoms such as itchy eyes, redness, and swelling. 4 , 2 , 6 However, it is important to be aware of the potential for rare side effects, such as fixed drug eruption. 9 Consult with a doctor to determine if olopatadine is a suitable treatment option for your specific needs and to discuss any potential risks.

Literature analysis of 13 papers
Positive Content
12
Neutral Content
0
Negative Content
1
Article Type
9
0
0
1
13
1.

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.

Author: AbelsonMark B, GomesPaul J, VogelsonCullen T, PasquineTerri A, TurnerF Darell, WellsDavid T, RobertsonStella M

Effective for allergic conjunctivitis
Safe treatment

Olopatadine hydrochloride ophthalmic solution is effective and safe for treating seasonal allergic conjunctivitis or rhinoconjunctivitis.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

2.

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.

Author: MahF S, O'BrienT, KimT, TorkildsenG

Allergic conjunctivitis treatment

This study evaluated the safety of olopatadine hydrochloride 0.2% in patients with both allergic conjunctivitis and dry eye. Olopatadine hydrochloride 0.2% is a topical ocular anti-allergic agent effective in treating ocular itching, the primary symptom of allergic conjunctivitis, and allows for once-daily dosing.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.

Author: MahF S, O'BrienT, KimT, TorkildsenG

Allergic conjunctivitis treatment

This study evaluated the safety of olopatadine hydrochloride 0.2% in patients with both allergic conjunctivitis and dry eye. Olopatadine hydrochloride 0.2% is a topical ocular anti-allergic agent effective in treating ocular itching, the primary symptom of allergic conjunctivitis, and allows for once-daily dosing.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.

Author: RosenwasserLanny J, O'BrienTerrence, WeyneJonathan

Allergic conjunctivitis treatment

This review discusses the mechanisms of seasonal allergic conjunctivitis and the role of topical solutions that interfere with histamine receptor activation and mast cell degranulation.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

5.

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.

Author: AbelsonMark B, GomesPaul J, VogelsonCullen T, PasquineTerri A, TurnerF Darell, WellsDavid T, RobertsonStella M

Effective for allergic conjunctivitis
Safe treatment

Olopatadine hydrochloride ophthalmic solution is effective and safe for treating seasonal allergic conjunctivitis or rhinoconjunctivitis.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

6.

Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study.

Author: NakataniHiroshi, GomesPaul, BradfordRon, GuoQiang, SafyanEleonora, HollanderDavid A

Allergic conjunctivitis prevention

This study compared the efficacy and safety of alcaftadine and olopatadine ophthalmic solutions for preventing allergen-mediated conjunctivitis in Japanese subjects. Alcaftadine 0.25% was more effective than vehicle and noninferior to olopatadine 0.1% in preventing itching and conjunctival hyperemia. Both drugs were well tolerated.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

7.

Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.

Author: MortemousqueB, BourcierT, KhairallahM, MessaoudR, Brignole-BaudouinF, RenaultD, RebikaH, Brémond-GignacD,

SAC symptom relief
ocular tolerance

Both preservative-free ketotifen 0.025% ophthalmic solution and preserved olopatadine 0.1% ophthalmic solution were found to be effective in treating seasonal allergic conjunctivitis (SAC). Ketotifen was slightly better tolerated.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

9.

Fixed drug eruption induced by topical olopatadine ophthalmic solution.

Author: BilgiliS G, KaradagA S, KaradagR, BulutG, CalkaO

Allergic conjunctivitis treatment
FDE

This report describes a case of fixed drug eruption (FDE) localized on the lateral side of the periorbital rim bilaterally in a 14-year-old male patient applying olopatadine 0.1% ophthalmic solution for the treatment of allergic conjunctivitis.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

11.

Use of olopatadine ophthalmic solution and reactivity of histamine skin testing.

Author: JonesJeremy D, TeminoViviana M, DworskiRyszard, AndersonCindy K, FahrenholzJohn M, AnAngel Qi

Accurate diagnosis
No suppression of testing

Accurate diagnosis of allergic rhinitis and conjunctivitis is essential, but antihistamines used for treatment can suppress histamine-induced skin testing. This study evaluated whether olopatadine hydrochloride ophthalmic solution affected skin-prick testing. Results indicate that olopatadine does not suppress wheal and flare responses during allergy testing, suggesting that discontinuation of the medication before testing may not be necessary.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Language : English

12.

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

Author: SpanglerDennis L, AbelsonMark B, OberAndrew, GotnesPaulo J

Allergy relief

This study found that exposure of the nasal mucosa to allergen resulted in allergic rhinitis, and exposure of the ocular surface to allergen resulted in conjunctivitis with a secondary effect in the nose. The topical ophthalmic solution provided the most effective management of allergic ocular signs and symptoms, and the nasal spray was most effective for nasal symptoms.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

13.

Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.

Author: LanierB Q, GrossR D, MarksB B, CockrumP C, JuniperE F

Allergic conjunctivitis treatment
Allergic rhinitis treatment

Olopatadine ophthalmic solution 0.1% is approved for the treatment of allergic conjunctivitis. Loratadine 10 mg is a nonsedating oral antihistamine approved for the treatment of allergic rhinitis.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.